Similar articles

• Toluene diisocyanates.

  [No authors listed] [No authors listed] Rep Carcinog. 2004;11:III256-8. Rep Carcinog. 2004. PMID: 21089973 No abstract available.
• Toluene diisocyanates.

  National Toxicology Program. National Toxicology Program. Rep Carcinog. 2011;12:414-6. Rep Carcinog. 2011. PMID: 21863111 No abstract available.
• Re: Dieter, M.P., Boorman, G.A., Jameson, C.W., Matthews, H.B., and Huff, J.E. (1990). "The carcinogenic activity of commercial grade toluene diisocyanate in rats and mice in relation to the metabolism of the 2,4- and 2,6-TDI isomers." Toxicol. Ind. Health 6: 599-621.

  Doe JE. Doe JE. Toxicol Ind Health. 1991 Jul;7(4):327-31. doi: 10.1177/074823379100700408. Toxicol Ind Health. 1991. PMID: 1663667 No abstract available.
• 2,4- and 2,6-toluene diisocyanates, 1,5-naphthalene diisocyanate, 4,4-methylenediphenyl diisocyanate and polymethylene polyphenyl isocyanate and flexible and rigid polyurethane foams.

  [No authors listed] [No authors listed] IARC Monogr Eval Carcinog Risk Chem Hum. 1979 Feb;19:303-40. IARC Monogr Eval Carcinog Risk Chem Hum. 1979. PMID: 220177 Review. No abstract available.
• Hypothesis-based weight-of-evidence evaluation of the human carcinogenicity of toluene diisocyanate.

  Prueitt RL, Rhomberg LR, Goodman JE. Prueitt RL, et al. Crit Rev Toxicol. 2013 May;43(5):391-435. doi: 10.3109/10408444.2013.790877. Epub 2013 May 15. Crit Rev Toxicol. 2013. PMID: 23675773 Review.